Adam R. Kalbermatten's most recent trade in KORU Medical Systems Inc was a trade of 32,000 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on Sept. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KORU Medical Systems Inc | Adam R. Kalbermatten | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 08 Sep 2026 | 32,000 | 394,017 (0%) | 0% | 3.2 | 101,120 | Common Stock |
| KORU Medical Systems Inc | Adam R. Kalbermatten | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2026 | 75,000 | 387,500 (0%) | 0% | 0 | Common Stock | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.26 per share. | 28 Jul 2026 | 25,483 | 362,017 (0%) | 0% | 4.3 | 108,558 | Common Stock |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 286,697 | 286,697 | - | - | Performance Stock Unit | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 284,091 | 284,091 | - | - | Performance Stock Unit | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President-Chief Commercial Off | Purchase of securities on an exchange or from another person at price $ 3.93 per share. | 11 Jun 2026 | 7,500 | 312,500 (0%) | 0% | 3.9 | 29,475 | Common Stick |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President-Chief Commercial Off | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 11 Jun 2026 | 5,000 | 305,000 (0%) | 0% | 4.0 | 19,800 | Common Stock |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President-Chief Commercial Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2026 | 67,779 | 67,779 | - | - | Option to buy Common Stock | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President-Chief Commercial Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2026 | 45,098 | 45,098 | - | - | Restricted Stock Unit | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | President-Chief Commercial Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2026 | 45,098 | 45,098 | - | - | Performance Stock Unit | |
| KORU Medical Systems Inc | Adam R. Kalbermatten | Chief Commercial Officer | 28 Jul 2025 | 600,000 | 600,000 | - | - | Option to buy Common Stock | ||
| KORU Medical Systems Inc | Adam R. Kalbermatten | Chief Commercial Officer | 28 Jul 2025 | 300,000 | 300,000 (0%) | 0% | 0 | Common Stock |